share_log

心動公司：授出購股權

XD INC: GRANT OF SHARE OPTIONS

香港交易所 ·  Jan 12 08:25
Summary by Moomoo AI
心動公司（XD Inc.）於2024年1月12日宣佈，根據2021年6月25日採納的購股權計劃，向合資格參與者授出合共1,875,305份購股權，用以認購公司普通股。該購股權的行使價為每股9.31港元，而授出當日股份收市價為每股9.14港元。購股權有效期為10年，且於授出當日立即歸屬。其中，公司董事會主席兼首席執行官黃一孟先生及執行董事兼總裁戴雲傑先生，作為公司主要股東，分別被授予83,210份及147,715份購股權。該授權行為已獲公司獨立非執行董事批准，且授出購股權旨在激勵參與者對公司的貢獻，並與公司及股東利益保持一致。授出購股權後，根據計劃尚餘約3197萬股可供未來授出。
心動公司（XD Inc.）於2024年1月12日宣佈，根據2021年6月25日採納的購股權計劃，向合資格參與者授出合共1,875,305份購股權，用以認購公司普通股。該購股權的行使價為每股9.31港元，而授出當日股份收市價為每股9.14港元。購股權有效期為10年，且於授出當日立即歸屬。其中，公司董事會主席兼首席執行官黃一孟先生及執行董事兼總裁戴雲傑先生，作為公司主要股東，分別被授予83,210份及147,715份購股權。該授權行為已獲公司獨立非執行董事批准，且授出購股權旨在激勵參與者對公司的貢獻，並與公司及股東利益保持一致。授出購股權後，根據計劃尚餘約3197萬股可供未來授出。
XD Inc. (XD Inc.) announced on January 12, 2024 that under the Share Option Plan adopted on June 25, 2021, it has granted a total of 1,875,305 shares to eligible participants to subscribe for the Company's ordinary shares. The exercise price of the share option is HK$9.31 per share and the issued share at the closing price of HK$9.14 per share on the date of issue. The share option is valid for 10 years and is vested immediately on the date of grant. Among them, Mr. Wong Yi-Meng, Chairman and Chief Executive Officer of the Company, and Mr. Dai Wan Jie, Executive Director and President, were granted 83,210 and 147,715 share purchase rights, respectively, as the Company's major shareholders. The authorization act has been approved...Show More
XD Inc. (XD Inc.) announced on January 12, 2024 that under the Share Option Plan adopted on June 25, 2021, it has granted a total of 1,875,305 shares to eligible participants to subscribe for the Company's ordinary shares. The exercise price of the share option is HK$9.31 per share and the issued share at the closing price of HK$9.14 per share on the date of issue. The share option is valid for 10 years and is vested immediately on the date of grant. Among them, Mr. Wong Yi-Meng, Chairman and Chief Executive Officer of the Company, and Mr. Dai Wan Jie, Executive Director and President, were granted 83,210 and 147,715 share purchase rights, respectively, as the Company's major shareholders. The authorization act has been approved by the Company's independent non-executive directors and the grant of share options is intended to incentivize participants' contributions to the Company and to align with the interests of the Company and its shareholders. Following the grant of the share option, approximately 3197 million shares remain available for future issuance under the Plan.

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more